Afuco™ Anti-Human TNFRSF21 ADCC Therapeutic Antibody (DQM3), ADCC Enhanced
Anti-TNFRSF21 ADCC Enhanced Antibody (DQM3) is an ADCC enhanced antibody produced by our Afuco™ platform. DQM3 is a functional agonist monoclonal antibody against DR6, which bound to the first cysteine-rich domain. Death receptor 6 (DR6) is a member of the death domain-containing receptors that belong to the TNFR superfamily.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-607CL |
| Pricing | Inquiry |
| Host | Human |
| Target | TNFRSF21 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | FC, Stim, IP |
| Storage | Short term: store at 4°C (over 6 months), long term: -20°C or -80°C. |